ORTEXORTEX News

Articles

Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.

All articles — 31243 total

Market Commentary

Bears Press Liquidia, Cerebras and Hertz Hard

Short sellers stepped up pressure on several mid-cap names this week, with LQDA (Liquidia Corporation) seeing the biggest notable move among larger stocks. Its SI % of FF jumped 8 percentage points in seven days to…

1 min read
Market Commentary

Money Flows East as Tech Bleeds

China attracted the most net new money in the past week, pulling in $11.1B of ETF inflows. Japan was close behind at $6.5B. The U.S. added $10.0B in net terms, but its flow imbalance score of 56.6 signals a market…

1 min read
ConfluencePNR

Pentair's Borrow Cost Triples as the Street Plays Catch-Up

PNR closed at $65.84 on October 29, up 24% over the past month, yet the cost to borrow its shares has tripled in a week. Three distinct signals are now moving together on a stock that was near a multi-year low less…

1 min read
Market Commentary

Earnings Avalanche Meets Index Chaos on Busy Friday

AAPL reports after the close tonight, the single biggest earnings print of the week by market cap at $5.1 trillion. Chip stocks are live ahead of the number. NVDA carries active options expiries every few days through…

1 min read
Market Commentary

Options Signals Cluster Around Chips and a Pharma Catalyst

Inovio Pharmaceuticals grabbed the options market's attention Friday. The FDA approved its plasmid DNA-based immunotherapy for recurrent respiratory papillomatosis. Calls running to the January 2027 expiry saw interest…

1 min read
Market Commentary

Earnings Avalanche Hits; Ferrari and Apple Lead the Week

Today marks the start of one of the busiest reporting weeks of the season. Nearly 2,000 companies are scheduled to report globally between now and Thursday. Today and tomorrow bring the heaviest European flow. SAF…

1 min read
Market Commentary

Pharma Bulls, Intel Bears: Today's Analyst Moves

Wells Fargo dominated analyst activity on Friday, with a sweeping set of target price changes across pharma and healthcare. The biggest upward call went to LLY. Wells Fargo raised its target on Eli Lilly from $1,330 to…

1 min read
Market Commentary

Uber COO Puts $5M Behind His Own Stock

UBER President and COO Andrew Gordon MacDonald filed two open-market purchases on September 8, totalling roughly $5.3M in Uber shares. He bought 54,325 shares on September 4 at an average price near $75.60, spending…

1 min read
Market Commentary

Bears Double Down: Short Sellers Circle Wolfspeed and Hertz

Short sellers sharpened their positions on several well-known names this week. Data from ORTEX as of 29 October shows the clearest movers and some notable extremes across the market. WOLF sits at 88.6% SI of free…

1 min read
ConfluenceGEV

HSBC upgrades GEV as options traders pare hedges

GE Vernova makes gas turbines, grid equipment, and wind technology. Its stock is up 7.3% over the past week, roughly in line with peers, and sits at $887.85 after a muted post-earnings session on October 29. Three…

1 min read
ConfluenceVIK

Short Sellers Pile Into Viking as Retail Attention Spikes

Short sellers have added roughly 2.4 million shares to their VIK position since mid-October. Shares short now stand at 10.35 million, equal to 3.3% of free float, up 27% over the past week and 26% over the past…

1 min read
Trader NoteFRW

Freightways: Cost to Borrow Quadruples as CFO Sells

FRW enters the final stretch of October with an unusual split: the stock is up 3.5% on the week while borrowing costs have risen sharply and insiders have been consistent sellers for two months. The most striking data…

1 min read
ConfluenceBCAX

Goldman Downgrades BCAX as Call Buyers Push Back

Goldman Sachs just cut Bicara Therapeutics to Sell and slashed its target 60% to $8. The stock has already lost 45% in a week. Yet options traders are betting the other way with unusual conviction. Why this matters: A…

1 min read
ConfluenceLLY

Lilly jumps 6.6% on Q3 beat as analysts lift targets

Eli Lilly and Company delivered its Q3 results on October 29, closing the day at $1,373.70, a 6.6% single-session gain that extended the stock's one-month rise to 16%. Within hours of the print, four analyst firms…

1 min read